17:37 IST
NSE
Results Update
Corona Remedies Results Update
CORONA Remedies reported Q1FY27 Revenue of ₹422.4 Crore, up 21.9% Y-o-Y, and PAT of ₹60.1 Crore, up 30.1% Y-o-Y, highlighting resilient growth.
Corona Remedies Ltd
- Share price
- ₹2,042.90
- Market cap
- ₹12,494 Cr
- Revenue (annual)
- ₹1,403 Cr
- Net profit (annual)
- ₹185.1 Cr
- P/E (TTM)
- 62.8×Sector 47.4×
- Promoter holding
- 69.00%+0.00% QoQ
- FII holding
- 3.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 4Financial Results 3Board Meeting Date 3Results Update 2Annual General Meeting 2Regulatory Approval 1Production Started 1Price Movement Clarification 1Other Announcement 1Dividend 1Capital Structure Change 1Board Meeting Outcome 1Annual Report 1
Time
2 announcements with these filters
17:42 IST
NSE
Results Update
Corona Remedies Results Update
CORONA Remedies reported FY26 revenue of ₹1,403.2 Crore, representing 17.3% growth. PAT grew 33.4%, driven by strong brand building and the WOKADINE acquisition.
- Value
- ₹1,403 Cr